Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1239

1.

Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: a pilot study.

Tatsukawa Y, Tsuge M, Kawakami Y, Hiyama Y, Murakami E, Kurihara M, Nomura M, Tsushima K, Uchida T, Nakahara T, Miki D, Kawaoka T, Abe-Chayama H, Imamura M, Aikata H, Ochi H, Hayes CN, Kawakami H, Chayama K.

Antivir Ther. 2019 Jan 11. doi: 10.3851/IMP3289. [Epub ahead of print] No abstract available.

PMID:
30632982
2.

The Clinical Usefulness of the PillCam Progress Indicator for Route Selection in Double Balloon Endoscopy.

Tsuboi A, Oka S, Tanaka S, Iio S, Otani I, Kunihara S, Chayama K.

Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.2043-18. [Epub ahead of print]

3.

Long-term prognosis after treatment for T1 carcinoma of laterally spreading tumors: a multicenter retrospective study.

Yamashita K, Oka S, Tanaka S, Nagata S, Kuwai T, Furudoi A, Tamura T, Kunihiro M, Okanobu H, Nakadoi K, Kanao H, Higashiyama M, Arihiro K, Kuraoka K, Shimamoto F, Chayama K.

Int J Colorectal Dis. 2019 Jan 3. doi: 10.1007/s00384-018-3203-7. [Epub ahead of print]

PMID:
30607579
4.

HOMA-IR is an independent predictor of advanced liver fibrosis in nondiabetic nonalcoholic fatty liver disease.

Fujii H, Imajo K, Yoneda M, Nakahara T, Hyogo H, Takahashi H, Hara T, Tanaka S, Sumida Y, Eguchi Y, Chayama K, Nakajima A, Nishimoto N, Kawada N.

J Gastroenterol Hepatol. 2019 Jan 1. doi: 10.1111/jgh.14595. [Epub ahead of print]

PMID:
30600551
5.

Gastric Cancer with Submucosal Invasion after Successful Helicobacter pylori Eradication: A Propensity Score-Matched Analysis of Patients with Annual Patient Endoscopic Survey.

Hata K, Ito M, Boda T, Kotachi T, Kiso M, Masuda K, Kurihara M, Kuroki K, Yorita N, Nagasaki N, Abduwali M, Tanaka S, Chayama K.

Digestion. 2019;99(1):59-65. doi: 10.1159/000494414. Epub 2018 Dec 14.

PMID:
30554223
6.

A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update.

Tateishi R, Uchino K, Fujiwara N, Takehara T, Okanoue T, Seike M, Yoshiji H, Yatsuhashi H, Shimizu M, Torimura T, Moriyama M, Sakaida I, Okada H, Chiba T, Chuma M, Nakao K, Isomoto H, Sasaki Y, Kaneko S, Masaki T, Chayama K, Koike K.

J Gastroenterol. 2018 Nov 29. doi: 10.1007/s00535-018-1532-5. [Epub ahead of print]

PMID:
30498904
7.

Early experience of seven hepatocellular carcinoma cases treated with regorafenib.

Uchikawa S, Kawaoka T, Aikata H, Kodama K, Inagaki Y, Hatooka M, Morio K, Nakahara T, Murakami E, Hiramatsu A, Tsuge M, Imamura M, Kawakami Y, Chayama K.

Clin Case Rep. 2018 Oct 11;6(11):2217-2223. doi: 10.1002/ccr3.1791. eCollection 2018 Nov.

8.

Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study.

Kishimoto S, Oki K, Maruhashi T, Kajikawa M, Matsui S, Hashimoto H, Takaeko Y, Kihara Y, Chayama K, Goto C, Aibara Y, Yusoff FM, Nakashima A, Noma K, Liao JK, Higashi Y.

J Hypertens. 2018 Nov 9. doi: 10.1097/HJH.0000000000001989. [Epub ahead of print]

PMID:
30418321
9.

The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy.

Nagaoki Y, Imamura M, Nishida Y, Daijo K, Teraoka Y, Honda F, Nakamura Y, Morio K, Fujino H, Nakahara T, Kawaoka T, Tsuge M, Hiramatsu A, Kawakami Y, Miki D, Hiyama Y, Ochi H, Chayama K, Aikata H.

J Med Virol. 2018 Nov 1. doi: 10.1002/jmv.25352. [Epub ahead of print]

PMID:
30381831
10.

Long-term Remission of Hepatitis-associated Aplastic Anemia Possibly due to Immunosuppressive Therapy after Liver Transplantation.

Kanamitsu K, Chayama K, Washio K, Yoshida R, Umeda Y, Yagi T, Shimada A.

Acta Med Okayama. 2018 Oct;72(5):515-518. doi: 10.18926/AMO/56250.

11.

Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non-alcoholic fatty liver disease.

Tanaka K, Takahashi H, Hyogo H, Ono M, Oza N, Kitajima Y, Kawanaka M, Chayama K, Saibara T, Anzai K, Eguchi Y.

Hepatol Res. 2018 Oct 27. doi: 10.1111/hepr.13282. [Epub ahead of print]

PMID:
30367534
12.

Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures.

Osawa M, Imamura M, Teraoka Y, Uchida T, Morio K, Fujino H, Nakahara T, Ono A, Murakami E, Kawaoka T, Miki D, Tsuge M, Hiramatsu A, Aikata H, Hayes CN, Chayama K; Hiroshima Liver Study Group.

J Gastroenterol. 2018 Oct 17. doi: 10.1007/s00535-018-1520-9. [Epub ahead of print]

PMID:
30334096
13.

Rectal Lymphoid Follicle Aphthous Lesions Frequently Progress to Ulcerative Colitis with Proximal Extension.

Hayashi R, Ueno Y, Tanaka S, Wakai M, Kumada J, Fujita A, Nomura M, Oka S, Ito M, Chayama K.

Intern Med. 2018 Oct 17. doi: 10.2169/internalmedicine.1635-18. [Epub ahead of print]

14.

Dual Red Imaging Maintains Clear Visibility During Colorectal Endoscopic Submucosal Dissection.

Tanaka H, Oka S, Tanaka S, Matsumoto K, Boda K, Yamashita K, Hirano D, Sumimoto K, Tamaru Y, Ninomiya Y, Hayashi N, Chayama K.

Dig Dis Sci. 2019 Jan;64(1):224-231. doi: 10.1007/s10620-018-5306-y. Epub 2018 Oct 4.

PMID:
30284651
15.

Chromosome 4q25 Variant rs6817105 Bring Sinus Node Dysfunction and Left Atrial Enlargement.

Tomomori S, Nakano Y, Ochi H, Onohara Y, Sairaku A, Tokuyama T, Motoda C, Matsumura H, Amioka M, Hironobe N, Okubo Y, Okamura S, Kawazoe H, Nishiyama Y, Tahara H, Chayama K, Kihara Y.

Sci Rep. 2018 Oct 1;8(1):14565. doi: 10.1038/s41598-018-32453-8.

16.

Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection.

Hayes CN, Zhang P, Zhang Y, Chayama K.

Viruses. 2018 Sep 28;10(10). pii: E531. doi: 10.3390/v10100531. Review.

17.

Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes.

Tsuge M, Hiraga N, Zhang Y, Yamashita M, Sato O, Oka N, Shiraishi K, Izaki Y, Makokha GN, Uchida T, Kurihara M, Nomura M, Tsushima K, Nakahara T, Murakami E, Abe-Chayama H, Kawaoka T, Miki D, Imamura M, Kawakami Y, Aikata H, Ochi H, Hayes CN, Fujita T, Chayama K.

Virology. 2018 Dec;525:48-61. doi: 10.1016/j.virol.2018.08.020. Epub 2018 Sep 18.

PMID:
30240958
18.

Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.

Takehara T, Sakamoto N, Nishiguchi S, Ikeda F, Tatsumi T, Ueno Y, Yatsuhashi H, Takikawa Y, Kanda T, Sakamoto M, Tamori A, Mita E, Chayama K, Zhang G, De-Oertel S, Dvory-Sobol H, Matsuda T, Stamm LM, Brainard DM, Tanaka Y, Kurosaki M.

J Gastroenterol. 2019 Jan;54(1):87-95. doi: 10.1007/s00535-018-1503-x. Epub 2018 Sep 10.

19.

[Changing concept of liver diseases in the era of hepatitis virus control].

Chayama K.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(9):765-767. doi: 10.11405/nisshoshi.115.765. Japanese. No abstract available.

PMID:
30197388
20.

Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals.

Bazerbachi F, Haffar S, Wang Z, Cabezas J, Arias-Loste MT, Crespo J, Darwish-Murad S, Ikram MA, Olynyk JK, Gan E, Petta S, Berzuini A, Prati D, de Lédinghen V, Wong VW, Del Poggio P, Chávez-Tapia NC, Chen YP, Cheng PN, Yuen MF, Das K, Chowdhury A, Caballeria L, Fabrellas N, Ginès P, Kumar M, Sarin SK, Conti F, Andreone P, Sirli R, Cortez-Pinto H, Carvalhana S, Sugihara T, Kim SU, Parikh P, Chayama K, Corpechot C, Kim KM, Papatheodoridis G, Alsebaey A, Kamath PS, Murad MH, Watt KD.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):54-64.e1. doi: 10.1016/j.cgh.2018.08.069. Epub 2018 Sep 7. Review.

PMID:
30196155

Supplemental Content

Loading ...
Support Center